即时询价 ×
* 必填项
请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。
Inquiry Online
×
* Required Fields.
Please complete the form below and we will contact you shortly.
Bulk Inquiry
×
* Required Fields.
Please complete the form below and we will contact you shortly.
CAS号 | 627908-92-3 | 货号 | BCP27700 |
中文名 | SU14813 | ||
英文名 | SU14813 | ||
中文别名 | |||
英文别名 | SU-14813;SU 14813; SU014813; SU-014813; SU 014813; | ||
SMILES | |||
化学名称 | |||
分子式 | C23H27FN4O4 | 分子量 | 442.48 |
纯度 | 98% | 配送 | 惯例下常温包邮 |
产品描述 | SU14813 is an oral, multitargeted tyrosine kinase inhibitor (TKI) targeting vascular endothelial growth factor receptors (VEGFR), platelet-derived growth factor receptors (PDGFR), KIT, and fms-like tyrosine kinase 3 (FLT-3) (1). SU14813 was developed as a next-generation TKI agent following sunitinib (SU11248) designed to demonstrate optimized pharmacokinetic (PK) and tolerability profiles. SU14813 demonstrated broad and potent antitumor activity equivalent to that of sunitinib, which resulted in tumor regression, growth arrest, growth delay, and prolonged survival in established xenograft cancer models in mice. |
Tags:SU14813 供应商,SU14813 购买,SU14813 生产,SU14813 批量,SU14813 供应,SU14813 订购,SU14813 采购